Sample Medication Use Guidelines
The chart below lists nonformulary medications and their formulary equivalents. The doses listed are representative equivalent doses and should be used to calculate other equivalent doses. For example, benazepril 20 mg should be changed to ramipril 5 mg.
Example Formulary Equivalents Chart
|
NONFORMULARY MEDICATION Dose |
FORMULARY EQUIVALENT Dose |
|
Alpha-1 Adrenergic Blockers |
|
|
Doxazosin (Cardura) 1 mg, 2 mg, 4 mg, 8 mg |
|
|
Angiotensin Converting Enzyme Inhibitors |
|
|
Ramipril (Altace) 2.5 mg |
|
|
Ramipril (Altace) 2.5 mg |
|
|
Ramipril (Altace) 2.5 mg |
|
|
Ramipril (Altace) 2.5 mg |
|
|
Moexipril (Univasc) 7.5 mg |
Ramipril (Altace) 2.5 mg |
|
Ramipril (Altace) 2.5 mg |
|
|
Ramipril (Altace) 2.5 mg |
|
|
Angiotensin Receptor Antagonists |
|
|
Losartan (Cozaar) 25 mg |
|
|
Losartan (Cozaar) 25 mg |
|
|
Losartan (Cozaar) 25 mg |
|
|
Losartan (Cozaar) 25 mg |
|
|
Antihistamines |
|
|
Fexofenadine (Allegra) 60 mg bid |
Loratidine (Claritin) 10 mg qd |
|
Fexofenadine (Allegra) 60 mg bid |
|
|
Benzodiazepines |
|
|
Diazepam 10 mg injection |
|
|
Flurazepam (Dalmane) 15 mg |
Temazepam (Restoril) 15 mg |
|
Oxazepam (Serax) 30 mg |
Lorazepam (Ativan) 2 mg |
|
Beta Adrenergic Blocking Agents |
|
|
Atenolol 50 mg/day |
|
|
Atenolol 50 mg/day |
|
|
Atenolol 50 mg/day |
|
|
Atenolol 50 mg/day or Propranolol 40 mg bid |
|
|
Atenolol 50 mg/day or Propranolol 40 mg bid |
|
|
Calcium Channel Blockers |
|
|
Diltiazem (Diltiazem CD) 120 mg |
|
|
Felodipine 5 mg/day |
|
|
Nicardipine 10 mg tid or 30 mg SR bid |
Felodipine 5 mg/day |
|
Nifedipine (Adalat CC) 30 mg |
Nifedipine (Procardia XL) 30 mg |
|
Nisoldipine 20 mg/day |
Felodipine 5 mg/day |
|
Verapamil SR 120 mg |
|
|
Diuretics |
|
|
Furosemide (Lasix) 40 mg |
|
|
Histamine-2 Receptor Antagonists |
|
|
Nizatidine 150 mg bid |
|
|
Nizatidine 150 mg bid |
|
|
Nizatidine 150 mg bid |
|
Example Summary of Restricted Drugs Listed by Services Responsible for Approval
*Pharmacists may approve for certain indications
|
Cardiology |
Coagulation |
Adult & Pediatric Infectious Diseases |
|
Abciximab (cath lab only) |
Anti-Hemophilic Factor, Porcine |
Amikacin* |
|
Amiodarone |
Anit-Inhibitor Complex |
ABLC* |
|
Flecainide |
Anit-Thrombin III |
Aztreonam* |
|
Propafenone |
Factor VIIa |
Ceftriaxone* |
|
Sotalol |
Lepirudin |
Cidofovir |
|
Tirofiban |
Fluconazole (IV and PO)* |
|
|
Tocainide |
ICUs only |
Foscarnet |
|
Ibutilide |
Itraconazole (PO)* |
|
|
Hematology/Oncology |
Propofol |
Meropenem for CF only |
|
All chemotherapy |
Quinupristin/dalfopristin |
|
|
Epoetin alfa (off label use) |
Dermatology |
Ticarcillin/clavulanate |
|
Ondansetron PO |
Isotretinoin |
Tobarmycin* |
|
Ondansetron IV |
Mechlorethamine Ointment |
Trimetrexate |
|
Methoxsalen |
Vancomycin (PO)* |
|
|
OB-Gyn |
||
|
Carboprost |
||
|
Opthalmology |
||
|
Natamycin |
||
|
Pilocarpine Inserts |
Example List of Restricted Medications
|
Drug |
Restriction |
|
Restricted to use in the Cardiac Catherization lab. |
|
|
Pediatric orders must be approved by the Pediatric Infectious Diseases Service. Adult use is not restricted. Pharmacists may approve for: 1. Documented Herpes simplex (HSV-1, HSV-2) and varicella zoster infections. |
|
|
All orders must be approved by the Adult or Pediatric Infectious Diseases Service. Pharmacists may approve use for:
|
|
|
All orders must be approved by the Cardiology Service. |
|
|
All orders must be approved by the Adult or Pediatric Infectious Diseases Service. Pharmacists may approve use if meets guidelines. Guidelines for use are as follows: The main advantage of liposomal amphotericin products is their reduced nephrotoxicity. Reserve use for situations where one of the following conditions are present:
|
|
|
All orders must be approved by the Coagulation Service. |
|
|
All orders must be approved by the Coagulation Service. |
|
|
All orders must be approved by the Coagulation Service (Pediatric Liver Transplant exempt) |
|
|
Available for use at 80 mg/day dosage only. Otherwise, substitute simvastatin per Formulary Equivalents Policy |
|
|
All orders must be approved by the Adult or Pediatric Infectious Diseases Service. Pharmacists may approve use for: 1. Infections caused by Gram-negative rods in patients allergic to penicillin with a history of anaphylactic reactions or allergy to a cephalosporin |
|
|
Restricted to use in the OR. |
Example Medication Hypertext Index